Zdrowie i gospodarka · 19/12/2019
FDA Announces Draft Guidance on Bridging for Drug-Device Combination Products
The FDA is releasing a draft guidance to help industry navigate the process of bridging for drug-device and biologic-device combination products, which aims to streamline development programs and meet performance goals under PDUFA VI.